{'fraction_non_alphanumeric': 0.031598513011152414, 'fraction_numerical': 0.01486988847583643, 'mean_word_length': 5.416666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Positron emission tomography and circulating tumor cells to monitor a dramatic response to gefitinib.

On November 2010, a 41-year-old man, a former light smoker, was admitted to our institution for a right lung nod-ule with pleural effusion, pericardial effusion, disseminated intravascular coagulation, and renal and hepatic failure. The Eastern Cooperative Oncology Group performance status was 4. PET scan demonstrated tracer accumulation in the right lung, pleural, supraclavicular and mediastinic lymph nodes, bone and liver (Fig. 1